Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 1, 2011, Pages 253-259

  He, Lijuan ^a   Shobnam, Nadia ^a   Hristova, Kalina ^a  

^a Johns Hopkins University   (United States)

Author keywords

Receptor tyrosine kinase; Signaling; Transmembrane domain

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; HETERODIMER; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE;

ARTICLE; CELL MEMBRANE; CELL STRAIN 3T3; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CROSS-LINKING REAGENTS; DIMERIZATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR PROTEIN-TYROSINE KINASES; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 78649797430     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.08.007     Document Type: Article

References (47)

1. J. Schlessinger Ligand-induced, receptor-mediated dimerization and activation of EGF receptor Cell 110 2002 669 672
2. V.P. Eswarakumar, I. Lax, and J. Schlessinger Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev. 16 2005 139 149
3. J. Schlessinger Common and distinct elements in cellular signaling via EGF and FGF receptors Science 306 2004 1506 1507
4. X. Zhang, J. Gureasko, K. Shen, P.A. Cole, and J. Kuriyan An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor Cell 125 2006 1137 1149
5. O. Kashles, D. Szapary, F. Bellot, A. Ullrich, J. Schlessinger, and A. Schmidt Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions Proc. Natl. Acad. Sci. U.S.A. 85 1988 9567 9571
6. C.D. Carpenter, H.A. Ingraham, C. Cochet, G.M. Walton, C.S. Lazar, J.M. Sowadski, M.G. Rosenfeld, and G.N. Gill Structural analysis of the transmembrane domain of the epidermal growth factor receptor J. Biol. Chem. 266 1991 5750 5755
7. L.M. Petti, P.M. Irusta, and D. DiMaio Oncogenic activation of the PDGF beta receptor by the transmembrane domain of p185neu* Oncogene 16 1998 843 851
8. B. Cheatham, S.E. Shoelson, K. Yamada, E. Goncalves, and C.R. Kahn Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1 Proc. Natl. Acad. Sci. U.S.A. 90 1993 7336 7340
9. J.M. Mendrola, M.B. Berger, M.C. King, and M.A. Lemmon The single transmembrane domains of ErbB receptors self-associate in cell membranes J. Biol. Chem. 277 2002 4704 4712
10. E.O. Artemenko, N.S. Egorova, A.S. Arseniev, and A.V. Feofanov Transmembrane domain of EphA1 receptor forms dimers in membrane-like environment Biochim. Biophys. Acta 1778 2008 2361 2367
11. L. Chen, M. Merzlyakov, T. Cohen, Y. Shai, and K. Hristova Energetics of ErbB1 transmembrane domain dimerization in lipid bilayers Biophys. J. 96 2009 4622 4630
12. E. Li, M. You, and K. Hristova FGFR3 dimer stabilization due to a single amino acid pathogenic mutation J. Mol. Biol. 356 2006 600 612
13. C. Finger, C. Escher, and D. Schneider The single transmembrane domains of human receptor tyrosine kinases encode self-interactions Sci. Signal 2 2009 ra56
14. D. Langosch, B. Brosig, H. Kolmar, and H.J. Fritz Dimerisation of the glycophorin A transmembrane segment in membranes probed with the ToxR transcription activator J. Mol. Biol. 263 1996 525 530
15. W. Ruan, V. Becker, U. Klingmuller, and D. Langosch The interface between self-assembling erythropoietin receptor transmembrane segments corresponds to a membrane-spanning leucine zipper J. Biol. Chem. 279 2004 3273 3279
16. D. Gerber, N. Sal-Man, and Y. Shai Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization J. Biol. Chem. 279 2004 21177 21182
17. C. Escher, F. Cymer, and D. Schneider Two GxxxG-like motifs facilitate promiscuous interactions of the human ErbB transmembrane domains J. Mol. Biol. 389 2009 10 16
18. M. You, E. Li, W.C. Wimley, and K. Hristova Forster resonance energy transfer in liposomes: measurements of transmembrane helix dimerization in the native bilayer environment Anal. Biochem. 340 2005 154 164
19. M. Merzlyakov, M. You, E. Li, and K. Hristova Transmembrane helix heterodimerization in lipid bilayers: probing the energetics behind autosomal dominant growth disorders J. Mol. Biol. 358 2006 1 7
20. M. Merzlyakov, and K. Hristova Forster resonance energy transfer measurements of transmembrane helix dimerization energetics Meth. Enzymol. 450 2008 107 127
21. E. Li, M. You, and K. Hristova Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands Biochemistry 44 2005 352 360
22. D.B. Weiner, J. Liu, J.A. Cohen, W.V. Williams, and M.I. Greene A point mutation in the neu oncogene mimics ligand induction of receptor aggregation Nature 339 1989 230 231
23. M.K. Webster, and D.J. Donoghue Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia EMBO J. 15 1996 520 527
24. G.A. Meyers, S.J. Orlow, I.R. Munro, K.A. Przylepa, and E.W. Jabs Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans Nat. Genet. 11 1995 462 464
25. E. Li, and K. Hristova Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies Biochemistry 45 2006 6241 6251
26. E. Li, and K. Hristova Receptor tyrosine kinase transmembrane domains: function, dimer structure and dimerization energetics Cell Adh. Migr. 4 2010 249 254
27. A. Bennasroune, M. Fickova, A. Gardin, S. Dirrig-Grosch, D. Aunis, G. Cremel, and P. Hubert Transmembrane peptides as inhibitors of ErbB receptor signaling Mol. Biol. Cell 15 2004 3464 3474
28. L. Roth, C. Nasarre, S. Dirrig-Grosch, D. Aunis, G. Cremel, P. Hubert, and D. Bagnard Transmembrane domain interactions control biological functions of neuropilin-1 Mol. Biol. Cell 19 2008 646 654
29. F.J. Lofts, H.C. Hurst, M.J. Sternberg, and W.J. Gullick Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo Oncogene 8 1993 2813 2820
30. A. Bennasroune, A. Gardin, C. Auzan, E. Clauser, S. Dirrig-Grosch, M. Meira, A. Appert-Collin, D. Aunis, G. Cremel, and P. Hubert Inhibition by transmembrane peptides of chimeric insulin receptors Cell. Mol. Life Sci. 62 2005 2124 2131
31. M.A. Lemmon, and D.M. Engelman Specificity and promiscuity in membrane helix interactions Q. Rev. Biophys. 27 1994 157 218
32. M.J. Sternberg, and W.J. Gullick A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization Protein Eng. 3 1990 245 248
33. B. Linggi, and G. Carpenter ErbB receptors: new insights on mechanisms and biology Trends Cell Biol. 16 2006 649 656
34. J. Drevs, M. Medinger, C. Schmidt-Gersbach, R. Weber, and C. Unger Receptor tyrosine kinases: the main targets for new anticancer therapy Curr. Drug Targets 4 2003 113 121
35. D. Harari, and Y. Yarden Molecular mechanisms underlying ErbB2/HER2 action in breast cancer Oncogene 19 2000 6102 6114
36. Z. Vajo, C.A. Francomano, and D.J. Wilkin The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans Endocr. Rev. 21 2000 23 39
37. C.G. L'Hote, and M.A. Knowles Cell responses to FGFR3 signalling: growth, differentiation and apoptosis Exp. Cell Res. 304 2005 417 431
38. B.W. van Rhijn, A.A. van Tilborg, I. Lurkin, J. Bonaventure, A. de Vries, J.P. Thiery, T.H. van der Kwast, E.C. Zwarthoff, and F. Radvanyi Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders Eur. J. Hum. Genet. 10 2002 819 824
39. D. Aviezer, M. Golembo, and A. Yayon Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia-genetic short limbed dwarfism Curr. Drug Targets 4 2003 353 365
40. C.I. Bargmann, M.C. Hung, and R.A. Weinberg Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 Cell 45 1986 649 657
41. C.I. Bargmann, and R.A. Weinberg Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion EMBO J. 7 1988 2043 2052
42. L. He, and K. Hristova Pathogenic activation of receptor tyrosine kinases in mammalian membranes J. Mol. Biol. 384 2008 1130 1142
43. Y.C. Chuan, D. Iglesias-Gato, L. Fernandez-Perez, A. Cedazo-Minguez, S.T. Pang, G. Norstedt, A. Pousette, and A. Flores-Morales Ezrin mediates c-Myc actions in prostate cancer cell invasion Oncogene 29 2010 1531 1542
44. J.M. Raats, and D. Hof Recombinant antibody expression vectors enabling double and triple immunostaining of tissue culture cells using monoclonal antibodies Eur. J. Cell Biol. 84 2005 517 521
45. B.O. Fanger, J.E. Stephens, and J.V. Staros High-yield trapping of EGF-induced receptor dimers by chemical cross-linking FASEB J. 3 1989 71 75
46. E. Monsonego-Ornan, R. Adar, T. Feferman, O. Segev, and A. Yayon The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation Mol. Cell. Biol. 20 2000 516 522
47. Y. Kokai, J.N. Myers, T. Wada, V.I. Brown, C.M. LeVea, J.G. Davis, K. Dobashi, and M.I. Greene Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts Cell 58 1989 287 292